Danny Popescu

CEO at Harbourfront Wealth Management in Vancouver, Canada

As CEO of Harbourfront Wealth Holdings, Danny Popescu directs all operations of this investment firm, including its Investment Dealer, Asset Management Firm and U.S. Investment divisions.

He established the company in Vancouver, British Columbia in 2013 to bring pension-type investment vehicles, such as private equity, private real estate and private debt, to Canadian retail investors.

Danny launched Harbourfront with an $11 million personal investment; within nine years, the enterprise value had risen to $425 million, when the Boston-based private equity firm Audax Group bought a stake in the company. With roughly 250 employees in 27 branches across Canada, Harbourfront Wealth Holdings is one of the fastest growing independent dealers in Canada. The company is now on track to reach a $1.5 to $2 billion enterprise value by 2027.

Before founding Harbourfront, Danny built and managed one of Vancouver’s largest private wealth management practices. By the time he was 32 years old, he ranked as the number one advisor at Canada’s largest asset management firm.

At 33 years of age, Danny became a partner at a national investment firm. At age 39 he was named one of Business in Vancouver’s Top Forty under 40. At age 46 he was named one of Canada’s Top 50 Industry Leaders of 2021 by Wealth Professional.

Danny's interests are not limited to the world of investing. Together with his wife, he established the Popescu Family Foundation which later evolved to the Harbourfront Gives Foundation. Together the foundations have raised and donated over $500,000 supporting 54 charitable organizations.

Danny’s support for deserving charities is active in every sense. In 2006, in an effort to raise funds and awareness for the hospital, he climbed Mt. Kilimanjaro, Africa’s highest peak. He has also raced in the Test of Metal, a 67-kilometer bicycle race along the mountain roads of British Columbia, to help the Canadian Diabetes Association raise funds for diabetes treatment and research.